Vol. 13, Issue 3, 2022September 30, 2022 EDT
ccby-nc-sa-4.0
Prevalence, relegation or resurruction: the future of single interfering RNA and antisense oligonucleotide APIs.
Prevalence, relegation or resurruction: the future of single interfering RNA and antisense oligonucleotide APIs.
siRNA Antisense oligonucleotide Excipients Bioactive excipient Orphan disease Gene silencing Gene knockdown Repurposed
Apte, Shireesh P. 2022. “Prevalence, Relegation or Resurruction: The Future of Single Interfering RNA and Antisense Oligonucleotide APIs.” International Journal of Pharmaceutical Excipients 13 (3).